Immune checkpoint inhibitors and type 1 diabetes mellitus: a case report and systematic review

OBJECTIVE: To better define the rare adverse event (AE) of diabetes mellitus associated with immune checkpoint inhibitors (ICIs). DESIGN AND METHODS: We report the case of a lung cancer patient with diabetic ketoacidosis (DKA) and autoimmune thyroiditis during pembrolizumab treatment. We provide a s...

Descripción completa

Detalles Bibliográficos
Autores principales: de Filette, Jeroen M K, Pen, Joeri J, Decoster, Lore, Vissers, Thomas, Bravenboer, Bert, Van der Auwera, Bart J, Gorus, Frans K, Roep, Bart O, Aspeslagh, Sandrine, Neyns, Bart, Velkeniers, Brigitte, Kharagjitsingh, Aan V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2019
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709545/
https://www.ncbi.nlm.nih.gov/pubmed/31330498
http://dx.doi.org/10.1530/EJE-19-0291

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709545/
https://www.ncbi.nlm.nih.gov/pubmed/31330498
http://dx.doi.org/10.1530/EJE-19-0291

Ejemplares similares